Predicting nerve damage with blood markers
Part of Brain & nervous system clinical trials.
This study looks at certain markers in the blood that may help predict how polyneuropathy (nerve damage) will progress. It involves physical tests, and results could help doctors better understand the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with polyneuropathy (nerve damage that causes numbness, tingling, or weakness) and it was confirmed with a nerve test called a nerve conduction study.
- You can read and understand Danish.
- You do not have any other health problems that would make it hard to do physical tests, unless those problems are not related to your polyneuropathy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at genetic differences in people being checked for a common type of nerve problem called distal symmetric polyneuropathy (nerve damage that usually affects the hands and feet). By understanding genetics, researchers hope to learn more about why neuropathic (nerve) pain happens and how it may differ between people.
This study looks at how well a nerve test result (the ratio of two nerve signals) can help tell apart types of peripheral neuropathy, and whether age affects that test's accuracy. It uses information from patients already evaluated at a specialized center.
This study uses ultrasound to look at the nerves of people who have polyneuropathy, a condition where nerves outside the brain and spinal cord are damaged. The goal is to see if ultrasound can help diagnose the condition better. If you have signs of polyneuropathy, this study might help you get a clearer diagnosis.
This study looks at whether certain markers in your blood can predict nerve damage from paclitaxel chemotherapy. If you join, researchers will monitor your nerve health during treatment to better understand and possibly prevent side effects.
This trial looks for and studies early nerve problems in the feet or legs that can happen with diabetes, before nerve damage is clearly diagnosed. It may help doctors better predict who is at risk and understand early changes.
This study looks at how well blood sugar is controlled in people with diabetes-related nerve damage, and measures how nerve signals travel through the leg. The goal is to understand whether better blood sugar control helps improve nerve function.
Hear when a new Polyneuropathies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.